These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9615120)

  • 21. Reporting drug product defects--JCAHO.
    Hoffmann RP
    Hosp Pharm; 1989 Feb; 24(2):143-4. PubMed ID: 10318199
    [No Abstract]   [Full Text] [Related]  

  • 22. [Some notes on the principles of correct and reasonable topical dermatologic treatment].
    Kalenský J
    Cesk Dermatol; 1975 Oct; 50(5):341-4. PubMed ID: 1192475
    [No Abstract]   [Full Text] [Related]  

  • 23. Drugs and the elderly. Topical analgesics.
    Todd B
    Geriatr Nurs; 1983; 4(3):152, 192, 196. PubMed ID: 6551302
    [No Abstract]   [Full Text] [Related]  

  • 24. Postmarketing management of drug use: toward rational public policy.
    Spitzer WO; Hutchinson T; Lane D
    CMAJ; 1987 May; 136(10):1022-4. PubMed ID: 3567760
    [No Abstract]   [Full Text] [Related]  

  • 25. Adverse drug reactions: a review of relevant factors.
    Ajayi FO; Sun H; Perry J
    J Clin Pharmacol; 2000 Oct; 40(10):1093-101. PubMed ID: 11028248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What should we know about hypersensitivity to peanuts in topical preparations.
    Gorgievska Sukarovska B; Lipozencić J; Stajminger G
    Acta Dermatovenerol Croat; 2007; 15(4):269-71. PubMed ID: 18093458
    [No Abstract]   [Full Text] [Related]  

  • 27. [Topical therapy in dermatology: pharmaceutical forms, excipients and bases for magistral preparations].
    Vennat B; Pouget MP; Pourrat A
    Ann Dermatol Venereol; 2000 Jan; 127(1):110-21. PubMed ID: 10717577
    [No Abstract]   [Full Text] [Related]  

  • 28. [Special features of topical and systemic dermatologic therapy in children].
    Lukas A; Wolf G; Fölster-Holst R
    J Dtsch Dermatol Ges; 2006 Aug; 4(8):658-78; quiz 679-80. PubMed ID: 16895569
    [No Abstract]   [Full Text] [Related]  

  • 29. The fingertip unit: A practical guide to topical therapy in children.
    Kalavala M; Mills CM; Long CC; Finlay AY
    J Dermatolog Treat; 2007; 18(5):319-20. PubMed ID: 17852630
    [No Abstract]   [Full Text] [Related]  

  • 30. Azelaic acid (Finacea) for rosacea.
    Med Lett Drugs Ther; 2003 Sep; 45(1165):76. PubMed ID: 12968125
    [No Abstract]   [Full Text] [Related]  

  • 31. Novel topical drug delivery systems and their potential use in acne vulgaris.
    Taglietti M; Hawkins CN; Rao J
    Skin Therapy Lett; 2008 Jun; 13(5):6-8. PubMed ID: 18648713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmaceutical postmarket review: fact or fiction?
    Schanz SJ
    Food Drug Law J; 2007; 62(3):493-500. PubMed ID: 17915391
    [No Abstract]   [Full Text] [Related]  

  • 33. [How to assess the risk of drugs?].
    Roujeau JC
    Ann Dermatol Venereol; 1998 Oct; 125(10):673-5. PubMed ID: 9835953
    [No Abstract]   [Full Text] [Related]  

  • 34. Reply: hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin.
    Chandrashekar L
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1348-9. PubMed ID: 17062068
    [No Abstract]   [Full Text] [Related]  

  • 35. Issues in bringing new drugs to the market.
    Ammann AJ
    Science; 2005 Dec; 310(5753):1425-6; author reply 1425-6. PubMed ID: 16329171
    [No Abstract]   [Full Text] [Related]  

  • 36. Postmarket surveillance for drug-eluting coronary stents: a comprehensive approach.
    Baim DS; Mehran R; Kereiakes DJ; Gross TP; Simons M; Malenka D; Kaplan AV
    Circulation; 2006 Feb; 113(6):891-7. PubMed ID: 16476863
    [No Abstract]   [Full Text] [Related]  

  • 37. [The Spanish drug surveillance system].
    Laporte JR; Capellà D
    Med Clin (Barc); 1994 Sep; 103(9):335-6. PubMed ID: 7967892
    [No Abstract]   [Full Text] [Related]  

  • 38. FDA attempting to overcome major roadblocks in monitoring drug safety.
    Zielinski SL
    J Natl Cancer Inst; 2005 Jun; 97(12):872-3. PubMed ID: 15956645
    [No Abstract]   [Full Text] [Related]  

  • 39. [Topical therapy of psorasis].
    Meurer M
    Hautarzt; 2006 Aug; 57(8):660. PubMed ID: 16855845
    [No Abstract]   [Full Text] [Related]  

  • 40. Scientific challenges in postmarketing surveillance of ocular adverse drug reactions.
    Fraunfelder FW; Fraunfelder FT
    Am J Ophthalmol; 2007 Jan; 143(1):145-149. PubMed ID: 17188050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.